| Year |
Citation |
Score |
| 2021 |
Lu RQ, Wu LX, Zhang J, Qin YZ, Liu YR, Lai YY, Jiang H, Chang YJ, Ruan GR, Huang XJ. Prognostic value of transcript levels in adult Philadelphia-negative B-cell acute lymphoblastic leukemia. Hematology (Amsterdam, Netherlands). 26: 9-15. PMID 33357137 DOI: 10.1080/16078454.2020.1860359 |
0.492 |
|
| 2019 |
Zhang J, Lu WY, Zhang JM, Lu RQ, Wu LX, Qin YZ, Liu YR, Lai YY, Jiang H, Jiang Q, Jiang B, Xu LP, Zhang XH, Huang XJ, Ruan GR, et al. S100A16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia. British Journal of Haematology. PMID 30916375 DOI: 10.1111/bjh.15878 |
0.484 |
|
| 2016 |
Shukla V, Shukla A, Joshi SS, Lu R. Interferon regulatory factor 4 attenuates notch signaling to suppress the development of chronic lymphocytic leukemia. Oncotarget. PMID 27232759 DOI: 10.18632/Oncotarget.9596 |
0.422 |
|
| 2016 |
Haney SL, Upchurch GM, Opavska J, Klinkebiel D, Hlady RA, Suresh A, Pirruccello SJ, Shukla V, Lu R, Costinean S, Rizzino A, Karpf AR, Joshi S, Swanson P, Opavsky R. Promoter Hypomethylation and Expression Is Conserved in Mouse Chronic Lymphocytic Leukemia Induced by Decreased or Inactivated Dnmt3a. Cell Reports. PMID 27134162 DOI: 10.1016/J.Celrep.2016.04.004 |
0.385 |
|
| 2016 |
Shukla A, Rai K, Shukla V, Chaturvedi NK, Bociek RG, Pirruccello SJ, Band H, Lu R, Joshi SS. Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL. Blood. PMID 26809508 DOI: 10.1182/Blood-2015-09-669317 |
0.62 |
|
| 2014 |
Shukla V, Lu R. IRF4 and IRF8: Governing the virtues of B Lymphocytes. Frontiers in Biology. 9: 269-282. PMID 25506356 DOI: 10.1007/S11515-014-1318-Y |
0.72 |
|
| 2014 |
Mittal AK, Chaturvedi NK, Rai KJ, Gilling-Cutucache CE, Nordgren TM, Moragues M, Lu R, Opavsky R, Bociek GR, Weisenburger DD, Iqbal J, Joshi SS. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease. Molecular Medicine (Cambridge, Mass.). 20: 290-301. PMID 24800836 DOI: 10.2119/Molmed.2012.00303 |
0.617 |
|
| 2014 |
Shukla V, Ma S, Joshi S, Lu R. Notch2 Is Critical for CLL Development in the IRF4-/-Vh11 Mice Blood. 124: 891-891. DOI: 10.1182/Blood.V124.21.891.891 |
0.66 |
|
| 2014 |
Shukla A, Rai K, Bociek G, Pirruccello SJ, Lu R, Joshi S. Role of Sprouty2 in the Pathogenesis of Chronic Lymphocytic Leukemia Blood. 124: 719-719. DOI: 10.1182/Blood.V124.21.719.719 |
0.616 |
|
| 2013 |
Pathak S, Ma S, Shukla V, Lu R. A role for IRF8 in B cell anergy. Journal of Immunology (Baltimore, Md. : 1950). 191: 6222-30. PMID 24218455 DOI: 10.4049/Jimmunol.1301169 |
0.768 |
|
| 2013 |
Shukla V, Ma S, Hardy RR, Joshi SS, Lu R. A role for IRF4 in the development of CLL. Blood. 122: 2848-55. PMID 23926303 DOI: 10.1182/Blood-2013-03-492769 |
0.612 |
|
| 2013 |
Ma S, Shukla V, Fang L, Gould KA, Joshi SS, Lu R. Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4. The Journal of Biological Chemistry. 288: 26430-40. PMID 23897826 DOI: 10.1074/Jbc.M113.475913 |
0.548 |
|
| 2012 |
Shukla V, Ma S, Uehling M, Joshi SS, Lu R. A Role for Interferon Regulatory Factor 4 in the Development of CLL Blood. 120: 714-714. DOI: 10.1182/Blood.V120.21.714.714 |
0.634 |
|
| 2012 |
Chaturvedi NK, Ahrens AK, Shukla A, Gilling CE, Mittal AK, Bierman P, Weisenburger DD, Lu R, Joshi SS. Stromal Tumor Microenvironment in CLL: Regulation of Leukemic Progression Blood. 120: 1781-1781. DOI: 10.1182/Blood.V120.21.1781.1781 |
0.462 |
|
| 2011 |
Pathak S, Ma S, Trinh L, Eudy J, Wagner KU, Joshi SS, Lu R. IRF4 is a suppressor of c-Myc induced B cell leukemia. Plos One. 6: e22628. PMID 21818355 DOI: 10.1371/Journal.Pone.0022628 |
0.764 |
|
| 2010 |
Ma S, Pathak S, Mandal M, Trinh L, Clark MR, Lu R. Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression. Molecular and Cellular Biology. 30: 4149-58. PMID 20566697 DOI: 10.1128/Mcb.00224-10 |
0.749 |
|
| 2010 |
Lien C, Fang CM, Huso D, Livak F, Lu R, Pitha PM. Critical role of IRF-5 in regulation of B-cell differentiation. Proceedings of the National Academy of Sciences of the United States of America. 107: 4664-8. PMID 20176957 DOI: 10.1073/Pnas.0911193107 |
0.581 |
|
| 2008 |
Lu R. Interferon regulatory factor 4 and 8 in B-cell development. Trends in Immunology. 29: 487-92. PMID 18775669 DOI: 10.1016/j.it.2008.07.006 |
0.629 |
|
| 2008 |
Pathak S, Ma S, Trinh L, Lu R. A role for interferon regulatory factor 4 in receptor editing. Molecular and Cellular Biology. 28: 2815-24. PMID 18285461 DOI: 10.1128/Mcb.01946-07 |
0.743 |
|
| 2008 |
Ma S, Pathak S, Trinh L, Lu R. Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development. Blood. 111: 1396-403. PMID 17971486 DOI: 10.1182/Blood-2007-08-110106 |
0.767 |
|
| 2006 |
Ma S, Turetsky A, Trinh L, Lu R. IFN regulatory factor 4 and 8 promote Ig light chain kappa locus activation in pre-B cell development. Journal of Immunology (Baltimore, Md. : 1950). 177: 7898-904. PMID 17114461 DOI: 10.4049/Jimmunol.177.11.7898 |
0.774 |
|
| 2003 |
Lu R, Medina KL, Lancki DW, Singh H. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes & Development. 17: 1703-8. PMID 12832394 DOI: 10.1101/Gad.1104803 |
0.571 |
|
| 2001 |
Lu R, Pitha PM. Monocyte differentiation to macrophage requires interferon regulatory factor 7. The Journal of Biological Chemistry. 276: 45491-6. PMID 11585813 DOI: 10.1074/JBC.C100421200 |
0.321 |
|
| Show low-probability matches. |